EFFECTS OF BETA-BLOCKING DRUGS IN ALCOHOL-WITHDRAWAL - A DOUBLE-BLIND COMPARATIVE-STUDY WITH PROPRANOLOL AND DIAZEPAM

被引:28
作者
BAILLY, D [1 ]
SERVANT, D [1 ]
BLANDIN, N [1 ]
BEUSCART, R [1 ]
PARQUET, PJ [1 ]
机构
[1] UNIV HOSP LILLE,DEPT INFORMAT,F-59000 LILLE,FRANCE
关键词
BETA-BLOCKING DRUGS; PROPRANOLOL; ALCOHOL WITHDRAWAL;
D O I
10.1016/0753-3322(92)90047-B
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Alcohol withdrawal is associated with a decrease in gamma-aminobutyric acid neurotransmission. This explains the efficacy of benzodiazepines. However, an increase in adrenergic activity may also play a part in alcohol withdrawal symptoms, suggesting a potential efficacy of beta-blocking drugs. A double-blind comparative study of propranolol and diazepam was carried out in 28 patients suffering from moderate uncomplicated alcohol withdrawal. Patients were treated for 15 days with either 75 mg of propranolol or 30 mg of diazepam. The results show that both drugs at the dosages used are equipotent in reducing physical withdrawal symptoms and anxiety symptoms. This suggests that most likely the central as well as the peripheral effects determine the clinical usefulness of propranolol in the management of alcohol withdrawal. However, propranolol is ineffective in preventing major motor seizures, suggesting that different neurobiological mechanisms underlie the alcohol withdrawal symptoms.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 27 条
[1]  
BAILLY D, 1990, SEM HOP PARIS, V66, P2448
[2]  
BAILLY D, 1987, B SOC FRANC ALCOOL, V9, P14
[3]  
BECKMANN H, 1977, ARCH PSYCH NEUROL SC, V224, P129
[4]   COMPARISON OF SOME PROPERTIES OF PRONETHALOL AND PROPRANOLOL [J].
BLACK, JW ;
DUNCAN, WAM ;
SHANKS, RG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1965, 25 (03) :577-+
[5]   PSYCHOLOGICAL EFFECTS OF PROPRANOLOL IN ABSTINENCE PHASE OF CHRONIC ALCOHOLICS [J].
CARLSSON, C ;
JOHANSSON, T .
BRITISH JOURNAL OF PSYCHIATRY, 1971, 119 (553) :605-+
[6]  
CARLSSON C, 1976, POSTGRAD MED J, V52, P166
[7]  
CARLSSON C, 1971, INT J CLIN PHARM TH, V3, P61
[8]  
CONNOR JD, 1967, J PHARMACOL EXP THER, V155, P545
[9]  
COVI L, 1984, CLIN NEUROPHARMAC S1, V7, P924
[10]  
DRW LRH, 1973, MED J AUSTRALIA, V2, P282